Apogee Therapeutics, Inc. APGE Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s change in accrued liabilities?
- Apogee Therapeutics, Inc. (APGE) reported change in accrued liabilities of $4.67M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s change in accrued liabilities increased by 77.0% year-over-year, from $2.64M to $4.67M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.